Clarithromycin · more major-labeled pairs than Nateglinide
SPL labels Clarithromycin + Nateglinide as major; Clarithromycin 16 / Nateglinide 1 in that band.
Mechanism on file: Clarithromycin can increase the amount of this diabetes medicine in your blood by slowing down how your body processes it.
FDA SPL severity: Major
Clarithromycin + Nateglinide · SPL mechanism field
Clarithromycin can increase the amount of this diabetes medicine in your blood by slowing down how your body processes it.
Major band excerpt · Clarithromycin with Nateglinide
Gastroprokinetic Agents: Cisapride Contraindicated Cisapride: [See Contraindications ( 4.2 )] Lipid-lowering agents: Lomitapide Lovastatin Simvastatin Contraindicated Lomitapide, Lovastatin, Simvastatin: Clarithromycin may increase the exposure of these drugs by inhibition of CYP3A metabolism, thereby increasing the risk of toxicities from these drugs [see Contraindications ( 4.5 ) and Warnings and Precautions ( 5.4 )] Atorvastatin, Pravastatin, Fluvastatin: [See Warnings and Precautions ( 5.4 )] Atorvastatin Pravastatin Use With Caution Fluvastatin No Dose Adjustment Hypoglycemic Agents:...
Clarithromycin · 16 major-labeled pairs (vs Nateglinide's 1)
- Atorvastatin major
- Colchicine major
- Cyclosporine major
- Dronedarone major
Nateglinide · 1 major + 9 total pairs
- Amiodarone minor
- Clonidine minor
- Fluconazole minor
- Leflunomide minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.